See Credit Details Below
Why You Should Attend:
Our expert faculty draws from years of experience working with the Food and Drug Administration and Consumer Product Safety Commission on regulatory issues spanning a range of products. Their discussion addresses how some products or issues may fall under FDA or CPSC jurisdiction, as well as some of the differences in dealing with these agencies, and strategies on how to land within the jurisdiction of your preferred agency.
What You Will Learn:
- Outlining the overview of dealing with the respective agency on potential safety issues: reporting requirements, recall process, enforcement authority and trends
- Recognizing overlapping jurisdiction: food packaging (CPSC/FDA, MOU), pharmaceutical and liquid nicotine packaging
- Comparing consumer product vs. medical device - Can companies pick their “regulatory path”? What are the benefits of picking one path over the other? What are the potential pitfalls?
- Understanding what companies need to know when dealing with CPSC or FDA, when that is not their primary regulator
Who Should Attend:
Attorneys involved in consumer product safety matters that implicate regulatory oversight from the FDA or CPSC should find this program to be helpful.
PLI’s Studio Briefings are on-demand video CLE programs that feature an intimate and engaging round table discussion format with legal and industry experts addressing a range of topics. Visit our landing page for our library of PLI Studio Briefings.